CHA
LVGO

Cooper/Haims Advisors’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Cooper/Haims Advisors’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,250
Closed -$244K – 61
2020
Q2 		$244K Sell
3,250
-4,750
-59% -$249K 0.2% 44
2020
Q1 		$228K Buy
+8,000
New +$207K 0.2% 39

Other funds holding LVGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cooper/Haims Advisors's LVGO Position: Q3 2020 in Review

Cooper/Haims Advisors sold out of Livongo Health, Inc. Common Stock (LVGO) in Q3 2020, closing a stake of 3,250 shares — an estimated $244K sold.

Cooper/Haims Advisors first reported a position in LVGO in Q1 2020 and held it in 2 quarters. The position peaked at $244K in Q2 2020. 391 funds tracked by Wall St. Rank hold LVGO as of Q3 2020.

  • Cooper/Haims Advisors reported no remaining Livongo Health, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Cooper/Haims Advisors sold 3,250 Livongo Health, Inc. Common Stock shares in Q3 2020, an estimated $244K.
  • Cooper/Haims Advisors first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Cooper/Haims Advisors's Livongo Health, Inc. Common Stock position peaked at $244K in Q2 2020.
  • 391 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q3 2020.

Based on Cooper/Haims Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.